What is the current price and market cap of VFX.AX stock?

VFX.AX stock closed at **A$0.095** on 08 Jan 2026 with a market cap of **A$8,219,996.00**. Volume was **105.00**, well below its average of **63,335.00**, which raises execution and liquidity considerations for traders.

What is Meyka AI's forecast for VFX.AX stock?

Meyka AI's forecast model projects a short-term rebound to **A$0.140** for VFX.AX stock, implying **47.37%** upside from **A$0.095**. Forecasts are model-based projections and not guarantees, and low liquidity increases risk.

What are the main risks when trading VFX.AX stock?

Main risks for VFX.AX stock include very low liquidity, negative EPS (**-0.05**), limited cash per share (**A$0.028**), and potential dilution from funding needs. Use tight sizing and confirm moves with volume.

What technical levels matter for an oversold bounce in VFX.AX stock?

Key trade levels for VFX.AX stock: support near **A$0.065** (stop), initial resistance at the 50-day **A$0.107**, secondary resistance at the 200-day **A$0.115**, and target **A$0.140** with stretch to **A$0.200**.

AU Stocks

VFX.AX Visionflex ASX A$0.095 08 Jan 2026: Oversold bounce to A$0.140

ByHuzaifa Zahoor January 8, 2026January 8, 2026

We closed Visionflex (VFX.AX) at A$0.095 on the ASX on 08 Jan 2026, leaving the share price stretched below moving averages and ripe for an oversold bounce. VFX.AX stock shows very low intraday volume at 105.00 shares versus an average of 63,335.00, and trades well under its 50-day average of A$0.107 and 200-day average of A$0.115. We assess why a measured rebound is plausible now, what the financials say, and how traders can size risk in a small-cap healthcare IT ticker on the ASX.